Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: JSC Pharmasyntez
Street 1: Presnenskay emb., 12
Street 2:
City: Moscow
Province:
Post Code: 123100
Country: Russian Federation
Phone: +7 495 750 5437
Email: moscow@pharmasyntez.com
Web Site: http://www.pharmasyntez.com

Focal Point Contact Information

Salutation: Dr.
First Name: Sergey
Last Name: Koren
Title: MD, PhD
Email: s.koren@pharmasyntez.com
Phone: +7 925 544 7324

Alternate Focal Point Contact Information

Salutation: Mr.
First Name: Vikram
Last Name: Punia
Title:  
Email: president@pharmasyntez.com
Phone:  

General Information

Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Is your organization legally registered in your country: Yes
Organization Reach: National
Organization Description:
JSC “Pharmasyntez” mission is to produce the latest pharmaceutical products of the highest quality that is available to patients, healthcare administrations and our partners. We are committed in the development and productions of innovative drugs. We are the only Russian Pharmaceutical company to develop a New Chemical Entity (NCE) “PERHLOZONE” for the treatment of Multi-Drug Resistant Tuberculosis (MDRTB). Our primary focus is to develop and manufacture innovative pharmaceuticals for the treatment of diseases which are socially significant like Anti-TB, Oncology, ARV’s and immune-modulators. Overall the primary mission of the company is to “Develop and manufacture innovative quality pharmaceuticals with a social responsibility”
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 100 +
Number of part-time staff who are directly involved with TB: 100 +
Number of volunteers who are directly involved with TB: 1 - 5
 
What is your organization's annual budget (USD) dedicated to TB? >$10 MIL
How did you hear about the Stop TB Partnership: Internet search
Why do you wish join the Stop TB Partnership: Network with other partners
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
AntiTB drugs production and distribution
 

Geographical Reach

Which country is your headquarters located in: Russian Federation
Which WHO region is the main focus of your work: Global
Which countries do you do operate in:
(This includes countries you are conducting activities in)
India
Indonesia
Iran (Islamic Republic of)
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Lithuania
Luxembourg
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia (Federated States of)
Monaco
Mongolia
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Republic of Korea
Republic of Moldova
Republic of Montenegro
Republic of Serbia
Romania
Russian Federation
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Tajikistan
Thailand
The Former Yugoslav Rep of Macedonia
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom of Great Britain and Northern Ireland
United Republic of Tanzania
United States of America
Uruguay

Specializations

Provision of TB products
Research and Development

Specializations in Countries

Provision of TB products Indonesia
Provision of TB products Iran (Islamic Republic of)
Provision of TB products Iraq
Provision of TB products Ireland
Provision of TB products Israel
Provision of TB products Italy
Provision of TB products Jamaica
Provision of TB products Japan
Provision of TB products Jordan
Provision of TB products Kazakhstan
Provision of TB products Kenya
Provision of TB products Kiribati
Provision of TB products Kuwait
Provision of TB products Kyrgyzstan
Provision of TB products Lao People's Democratic Republic
Provision of TB products Latvia
Provision of TB products Lebanon
Provision of TB products Lesotho
Provision of TB products Liberia
Provision of TB products Libyan Arab Jamahiriya
Provision of TB products Lithuania
Provision of TB products Luxembourg
Provision of TB products Madagascar
Provision of TB products Malawi
Provision of TB products Malaysia
Provision of TB products Maldives
Provision of TB products Mali
Provision of TB products Malta
Provision of TB products Marshall Islands
Provision of TB products Mauritania
Provision of TB products Mauritius
Provision of TB products Mexico
Provision of TB products Micronesia (Federated States of)
Provision of TB products Monaco
Provision of TB products Mongolia
Provision of TB products Morocco
Provision of TB products Mozambique
Provision of TB products Myanmar
Provision of TB products Namibia
Provision of TB products Nauru
Provision of TB products Nepal
Provision of TB products Netherlands
Provision of TB products New Zealand
Provision of TB products Nicaragua
Provision of TB products Niger
Provision of TB products Nigeria
Provision of TB products Niue
Provision of TB products Norway
Provision of TB products Oman
Provision of TB products Pakistan
Provision of TB products Palau
Provision of TB products Panama
Provision of TB products Papua New Guinea
Provision of TB products Paraguay
Provision of TB products Peru
Provision of TB products Philippines
Provision of TB products Poland
Provision of TB products Portugal
Provision of TB products Qatar
Provision of TB products Republic of Korea
Provision of TB products Republic of Moldova
Provision of TB products Republic of Montenegro
Provision of TB products Republic of Serbia
Provision of TB products Romania
Provision of TB products Russian Federation
Provision of TB products Rwanda
Provision of TB products Saint Kitts and Nevis
Provision of TB products Saint Lucia
Provision of TB products Saint Vincent and the Grenadines
Provision of TB products Samoa
Provision of TB products San Marino
Provision of TB products Sao Tome and Principe
Provision of TB products Saudi Arabia
Provision of TB products Senegal
Provision of TB products Seychelles
Provision of TB products Sierra Leone
Provision of TB products Singapore
Provision of TB products Slovakia
Provision of TB products Slovenia
Provision of TB products Solomon Islands
Provision of TB products Somalia
Provision of TB products South Africa
Provision of TB products South Sudan
Provision of TB products Spain
Provision of TB products Sri Lanka
Provision of TB products Sudan
Provision of TB products Suriname
Provision of TB products Swaziland
Provision of TB products Sweden
Provision of TB products Switzerland
Provision of TB products Syrian Arab Republic
Provision of TB products Tajikistan
Provision of TB products Thailand
Provision of TB products The Former Yugoslav Rep of Macedonia
Provision of TB products Togo
Provision of TB products Tonga
Provision of TB products Trinidad and Tobago
Provision of TB products Tunisia
Provision of TB products Turkey
Provision of TB products Turkmenistan
Provision of TB products Tuvalu
Provision of TB products Uganda
Provision of TB products Ukraine
Research and Development India
Research and Development Indonesia
Research and Development Iran (Islamic Republic of)
Research and Development Iraq
Research and Development Ireland
Research and Development Israel
Research and Development Italy
Research and Development Jamaica
Research and Development Japan
Research and Development Jordan
Research and Development Kazakhstan
Research and Development Kenya
Research and Development Kiribati
Research and Development Kuwait
Research and Development Kyrgyzstan
Research and Development Lao People's Democratic Republic
Research and Development Latvia
Research and Development Lebanon
Research and Development Lesotho
Research and Development Liberia
Research and Development Libyan Arab Jamahiriya
Research and Development Lithuania
Research and Development Luxembourg
Research and Development Madagascar
Research and Development Malawi
Research and Development Malaysia
Research and Development Maldives
Research and Development Mali
Research and Development Malta
Research and Development Marshall Islands
Research and Development Mauritania
Research and Development Mauritius
Research and Development Mexico
Research and Development Micronesia (Federated States of)
Research and Development Monaco
Research and Development Mongolia
Research and Development Morocco
Research and Development Mozambique
Research and Development Myanmar
Research and Development Namibia
Research and Development Nauru
Research and Development Nepal
Research and Development Netherlands
Research and Development New Zealand
Research and Development Nicaragua
Research and Development Niger
Research and Development Nigeria
Research and Development Niue
Research and Development Norway
Research and Development Oman
Research and Development Pakistan
Research and Development Palau
Research and Development Panama
Research and Development Papua New Guinea
Research and Development Paraguay
Research and Development Peru
Research and Development Philippines
Research and Development Poland
Research and Development Portugal
Research and Development Qatar
Research and Development Republic of Korea
Research and Development Republic of Moldova
Research and Development Republic of Montenegro
Research and Development Republic of Serbia
Research and Development Romania
Research and Development Russian Federation

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Drug-Resistant TB:
Has conducted 3 Phase clinical trials on novel anti MDR TB drug Perchlozone.

TB-HIV:
Will continue clinical studies on novel antiTB drugs in HIV positive patients (safety and including drug to drug interactions)

Laboratory Strengthening:
Has own laboratory

New TB Drugs:
Has Phase 3 finished novel antiTB and anti MDR TB drug Perchlozone
Have several new substances to be studied

Fundamental Research:
Searching for new antiTB drugs and moleculs

Operational Research:
New treatment regimen development

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: July 9, 2012
Last updated: July 9, 2012